tiprankstipranks
Gyre Therapeutics (GYRE)
NASDAQ:GYRE
Holding GYRE?
Track your performance easily

Gyre Therapeutics (GYRE) Financial Statements

802 Followers

Gyre Therapeutics Financial Overview

Gyre Therapeutics's market cap is currently ―. The company's EPS TTM is $-17.572; its P/E ratio is -0.67; Gyre Therapeutics is scheduled to report earnings on April 1, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Sep 23Jun 23
Income Statement-
Total Revenue$ 25.49M$ 25.23M$ 27.17M-$ 29.33M
Gross Profit$ 24.53M$ 24.45M$ 26.19M-$ 28.25M
EBIT$ 3.41M$ 5.68M$ 12.15M$ -1.58M$ 5.60M
EBITDA$ 3.86M$ 5.92M$ 12.58M$ -1.58M$ 5.92M
Net Income Common Stockholders$ 1.12M$ 3.53M$ 7.53M$ -1.58M$ 1.85M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 25.09M$ 25.10M$ 37.35M$ 2.23M$ 6.92M
Total Assets$ 125.24M$ 120.93M$ 122.01M$ 9.96M$ 12.39M
Total Debt$ 1.79M$ 1.96M$ 275.00K$ 0.00$ 0.00
Net Debt$ -23.30M$ -23.14M$ -37.08M$ -2.23M$ -6.92M
Total Liabilities$ 26.77M$ 27.58M$ 33.24M$ 6.45M$ 7.40M
Stockholders Equity$ 63.18M$ 60.35M$ 56.64M$ 3.52M$ -28.31M
Cash Flow-
Free Cash Flow$ 1.02M$ -6.73M$ 2.70M$ -3.22M$ 2.17M
Operating Cash Flow$ 1.73M$ -5.49M$ 2.88M$ -3.22M$ 3.15M
Investing Cash Flow$ -2.39M$ -8.27M$ -7.22M-$ -6.71M
Financing Cash Flow$ 324.00K$ 156.00K$ 658.00K$ -1.48M$ -11.12M
Currency in USD

Gyre Therapeutics Earnings and Revenue History

Gyre Therapeutics Debt to Assets

Gyre Therapeutics Cash Flow

Gyre Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis